A detailed history of K2 Principal Fund, L.P. transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 171,200 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171,200
Previous 643,100 73.38%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
N/A
-835,202 Reduced 27.34%
2,219,131 $0
Q4 2023

Feb 14, 2024

BUY
N/A
502,271 Added 19.68%
3,054,333 $0
Q3 2023

Nov 13, 2023

BUY
N/A
1,280,318 Added 100.67%
2,552,062 $0
Q2 2023

Aug 14, 2023

SELL
N/A
-1,414,746 Reduced 52.66%
1,271,744 $0
Q1 2023

May 11, 2023

SELL
N/A
-185,658 Reduced 6.46%
2,686,490 $0
Q4 2022

Feb 10, 2023

SELL
$0.0 - $6.07 $0 - $2.28 Million
-375,385 Reduced 11.56%
2,872,148 $0
Q3 2022

Nov 14, 2022

BUY
$3.91 - $5.52 $6.67 Million - $9.42 Million
1,705,827 Added 110.65%
3,247,533 $16.9 Million
Q2 2022

Aug 12, 2022

BUY
$2.9 - $4.44 $4.47 Million - $6.85 Million
1,541,706 New
1,541,706 $6.54 Million

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.